Paper
0
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Authors
Published
Mar 26, 2007
Show more
Save
Tip0
TipSave
Abstract
Levels of high-density lipoprotein (HDL) cholesterol are inversely related to cardiovascular risk. Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, increases HDL cholesterol levels, but the functional effects associated with this mechanism remain uncertain.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.